These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18941365)

  • 1. Deaths due to cutaneous T-Cell lymphoma: bias of certification and a revised estimate of national mortality.
    Barzilai DA; Weinstock MA
    Epidemiology; 2008 Sep; 19(5):761-2. PubMed ID: 18941365
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous lymphomas reported to the National Cancer Institute's surveillance, epidemiology, and end results program: applying the new WHO-European Organisation for Research and Treatment of Cancer classification system.
    Dores GM; Anderson WF; Devesa SS
    J Clin Oncol; 2005 Oct; 23(28):7246-8. PubMed ID: 16192622
    [No Abstract]   [Full Text] [Related]  

  • 3. Validation of cause-of-death certification for outpatient cancers: the contrasting cases of melanoma and mycosis fungoides.
    Weinstock MA; Reynes JF
    Am J Epidemiol; 1998 Dec; 148(12):1184-6. PubMed ID: 9867264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-year survival data not always a good measure of progress.
    Schmidt C
    J Natl Cancer Inst; 2006 Dec; 98(24):1761. PubMed ID: 17179474
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence Trends of Primary Cutaneous T-Cell Lymphoma in the US From 2000 to 2018: A SEER Population Data Analysis.
    Cai ZR; Chen ML; Weinstock MA; Kim YH; Novoa RA; Linos E
    JAMA Oncol; 2022 Nov; 8(11):1690-1692. PubMed ID: 36048455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations and biases of the Surveillance, Epidemiology, and End Results database.
    Park HS; Lloyd S; Decker RH; Wilson LD; Yu JB
    Curr Probl Cancer; 2012; 36(4):216-24. PubMed ID: 22481009
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term survivors of childhood cancers in the United States.
    Mariotto AB; Rowland JH; Yabroff KR; Scoppa S; Hachey M; Ries L; Feuer EJ
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1033-40. PubMed ID: 19336557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dewey defeats Truman and cancer statistics.
    Friedenson B
    J Natl Cancer Inst; 2009 Aug; 101(16):1157. PubMed ID: 19561316
    [No Abstract]   [Full Text] [Related]  

  • 10. The validity of race and Hispanic origin reporting on death certificates in the United States.
    Arias E; Schauman WS; Eschbach K; Sorlie PD; Backlund E
    Vital Health Stat 2; 2008 Oct; (148):1-23. PubMed ID: 19024798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-cause mortality among Hispanics in the United States: exploring heterogeneity by nativity status, country of origin, and race in the National Health Interview Survey-linked Mortality Files.
    Borrell LN; Crawford ND
    Ann Epidemiol; 2009 May; 19(5):336-43. PubMed ID: 19230710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing incidence trends of cutaneous B-cell lymphoma.
    Korgavkar K; Weinstock MA
    J Invest Dermatol; 2014 Mar; 134(3):840-842. PubMed ID: 24037340
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal subcutaneous panniculitis-like T-cell lymphoma gamma/delta subtype (cutaneous gamma/delta T-cell lymphoma): report of a case and review of the literature.
    Kao GF; Resh B; McMahon C; Gojo I; Sun CC; Phillips D; Zhao XF
    Am J Dermatopathol; 2008 Dec; 30(6):593-9. PubMed ID: 19033937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-positive illicit-drug findings: implications for cause-of-death certification, classification and coding.
    Lahti RA; Korpi H; Vuori E
    Forensic Sci Int; 2009 May; 187(1-3):14-8. PubMed ID: 19303228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous lymphomas: what can we learn from location?
    Grange F; Antonicelli F
    Arch Dermatol; 2009 Jun; 145(6):710-2. PubMed ID: 19528430
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma.
    Kiessling MK; Klemke CD; Kaminski MM; Galani IE; Krammer PH; Gülow K
    Cancer Res; 2009 Mar; 69(6):2365-74. PubMed ID: 19258503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of younger vs older women with vulvar cancer in the United States.
    Kumar S; Shah JP; Bryant CS; Imudia AN; Morris RT; Malone JM
    Am J Obstet Gynecol; 2009 May; 200(5):e52-5. PubMed ID: 19110228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous aspergillosis in a patient with cutaneous T-cell lymphoma.
    Yuanjie Z; Jingxia D; Hai W; Jianghan C; Julin G
    Mycoses; 2009 Sep; 52(5):462-4. PubMed ID: 18983429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous T-cell lymphoma expressing FOXP3: a case report supporting the existence of malignancies of regulatory T cells.
    Marzano AV; Vezzoli P; Fanoni D; Venegoni L; Berti E
    J Am Acad Dermatol; 2009 Aug; 61(2):348-55. PubMed ID: 19615546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.